| Literature DB >> 33340498 |
Bi-Xin Zheng1, Ayma Malik2, Ming Xiong1, Alex Bekker1, Yuan-Xiang Tao3.
Abstract
Neuropathic pain is the most common clinical disorder destroying the quality of patient life and leading to a marked economic and social burden. Opioids are still last option for pharmacological treatment of this disorder, but their antinociceptive effects are limited in part due to the downregulation of opioid receptors in the primary afferent neurons after peripheral nerve trauma. How this downregulation occurs is not completely understood, but recent studies have demonstrated that peripheral nerve trauma drives the alterations in epigenetic modifications (including DNA methylation, histone methylation and mciroRNAs), expression of transcription factors, post-transcriptional modifications (e.g., RNA methylation) and protein translation initiation in the neurons of nerve trauma-related dorsal root ganglion (DRG) and that these alternations may be associated with nerve trauma-caused downregulation of DRG opioid receptors. This review presents how opioid receptors are downregulated in the DRG after peripheral nerve trauma, specifically focusing on distinct molecular mechanisms underlying transcriptional and translational processes. This review also discusses how this downregulation contributes to the induction and maintenance of neuropathic pain. A deeper understanding of these molecular mechanisms likely provides a novel avenue for prevention and/or treatment of neuropathic pain.Entities:
Keywords: Dorsal root ganglion; Downregulation; Molecular mechanisms; Neuropathic pain; Opioid receptors
Mesh:
Substances:
Year: 2020 PMID: 33340498 PMCID: PMC7870536 DOI: 10.1016/j.expneurol.2020.113572
Source DB: PubMed Journal: Exp Neurol ISSN: 0014-4886 Impact factor: 5.330